Kilitch Drugs (India) Limited — Others, 21-05-2025: Copy of Newspaper Publication

Kilitch Drugs has announced a board meeting to consider the financial results for the quarter and half-year. Its consolidated audited results show total income of ₹62.92 Cr for the quarter and ₹209.48 Cr for the year. Net profit after tax was ₹10.22 Cr for the quarter and ₹24.94 Cr for the year, with earnings per share at ₹6.47 (basic and diluted) for the year. The numbers indicate steady growth, underscoring the company’s operational stability and improving profitability.